News

JD Supra8d
AstraZeneca refused interim injunction on SPC for blockbuster diabetes treatment against Glenmark but swiftly obtains permission to appeal
Michael Tappin KC, sitting as a deputy judge of the High Court, refused to grant AstraZeneca (“AZ”) an interim injunction ...
JD Supra5d
UK Court of Appeal grants AstraZeneca an interim injunction against Glenmark’s generic dapagliflozin for type II diabetes
In a reversal of fortune, yesterday (9 April) the UK Court of Appeal awarded AstraZeneca (AZ) an interim injunction keeping Glenmark’s ...
pharmaphorum5d
Jardiance cleared in EU for CKD, challenging Forxiga
and means that Boehringer and Lilly can now compete head to head across all three indications with AstraZeneca's Forxiga (dapagliflozin). AZ's drug was approved for CKD in the EU and US in 2021 ...
pharmaphorum6y
AZ's diabetes drug Forxiga approved in EU for type 1 disease
AstraZeneca’s diabetes drug Forxiga (dapagliflozin) has been approved in the EU in patients with type 1 disease. Forxiga has been approved as an adjunct to insulin in patients with a BMI greater ...